Researchers from Morphic Therapeutic Inc. and affiliated organizations published data from a study that aimed to assess the potential of using arginylglycylaspartic acid (RGD) integrins for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback